Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services 
Gold Prices Stabilize in Asian Trade After Sharp Weekly Losses Amid Fed Uncertainty 
U.S. Stock Futures Rise as Investors Eye Big Tech Earnings and AI Momentum 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
Indian Rupee Strengthens Sharply After U.S.-India Trade Deal Announcement 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff 
RBA Raises Interest Rates by 25 Basis Points as Inflation Pressures Persist 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
Gold and Asian Stocks Rebound as Market Volatility Eases and Global Sentiment Improves 
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
